The first COVID-19 vaccines for newborns and preschoolers were approved by US regulators on Friday, June 17, paving the path...
Read moreRoche is exploring new products to refill its blood cancer armoury after Rituxan's patent expiration. Swiss pharma is launching a...
Read moreAmerisourceBergen makes strategic investments, deploys solutions to raise its end-to-end suite of commercialization services, ushering in new monetization era. The...
Read moreProteros biostructures GmbH, situated in Munich, has expanded its epigenetic medicine collaboration with AstraZeneca. This multi-year extension builds on a...
Read moreSEQENS, an integrated leader in the manufacturing of active ingredients and pharmaceutical intermediates, announced a multi-million-dollar investment in its research...
Read moreSanofi and Exscientia announced a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule candidates...
Read moreAlthough we cannot say that it was unheard of, collaboration on the basis of interdisciplinary and interprofessional elements has always...
Read moreAbbVie and the University of Chicago and have extended their collaboration agreement through 2025 to support preclinical oncology research. To...
Read moreBiognosys, a leader in proteomics solutions for drug discovery and development, announces the launch of its next-generation blood biomarker discovery...
Read moreLife Science Newswire – Astellas Venture Management LLC, a wholly-owned venture capital subsidiary of Astellas Pharma Inc, and We are...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.